Back
Theravance Biopharma Quote, Financials, Valuation and Earnings
He cracked the code to crypto
Now he says a new two-year bull market has begun. And he likes one altcoin above all others.
Sell
47
TBPH
Theravance Biopharma
Last Price:
9.11
Seasonality Move:
-13.46%
7 Day Trial
ALL ACCESS PASS
$
7
NOW is the time to get in on this trillion-dollar megatrend
Get it here.Theravance Biopharma Price Quote
$9.11
-0.01 (-0.33%)
(Updated: April 27, 2024 at 6:23 AM ET)
Theravance Biopharma Key Stats
Sell
47
Theravance Biopharma (TBPH)
is a Sell
Day range:
$9.06 - $9.27
52-week range:
$8.21 - $11.98
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.79
P/B ratio:
2.06%
Volume:
263.5K
Avg. volume:
420K
1-year change:
-17.76%
Market cap:
$439.3M
Revenue:
$57.4M
EPS:
$-0.97
How Much Does Theravance Biopharma Make?
-
How Much Are Theravance Biopharma's Sales Annually?
TBPH Revenues are $57.4M -
How Much Profit Does Theravance Biopharma's Make A Year?
TBPH net income is -$55.2M
Is Theravance Biopharma Growing As A Company?
-
What Is Theravance Biopharma's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.2% -
What Is Theravance Biopharma's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Theravance Biopharma Stock Price Performance
-
Did Theravance Biopharma Stock Go Up Last Month?
Theravance Biopharma share price went up by 3.4% last month -
Did TBPH's Share Price Rise Over The Last Year?
TBPH share price fell by -17.76% over the past 1 year
What Is Theravance Biopharma 52-Week High & Low?
-
What Is Theravance Biopharma’s 52-Week High Share Price?
Theravance Biopharma has traded as high as $11.98 over the past 52 weeks -
What Is Theravance Biopharma’s 52-Week Low Share Price?
Theravance Biopharma has traded as low as $8.21 over the past 52 weeks
Theravance Biopharma Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Theravance Biopharma?
-
How Much Debt Does Theravance Biopharma Have?
Total long term debt quarterly is $0 -
How Much Cash Does Theravance Biopharma Have?
Cash and short term investments quarterly total is $102.4M -
What Is Theravance Biopharma’s Book Value Per Share?
Book value per share is 4.43
Is Theravance Biopharma Cash Flow Positive?
-
What Is TBPH Cash Flow From Operations?
Cash flow from operations (TTM) is -$27M -
What Is Theravance Biopharma’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$198.9M -
What Is Theravance Biopharma’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$32.7M
Theravance Biopharma Return On Invested Capital
-
Is Management Doing A Good Job?
TBPH return on invested capital is -17.79% -
What Is Theravance Biopharma Return On Assets?
ROA measures how assets are converting to revenues and is -11.56% -
What Is TBPH Return On Equity?
ROE is a measure of profitability and is -17.79%
Theravance Biopharma Earnings Date & Stock Price
-
What Is Theravance Biopharma's Stock Price Today?
A single share of TBPH can be purchased today for 9.12 -
What Is Theravance Biopharma’s Stock Symbol?
Theravance Biopharma trades on the nasdaq under the ticker symbol: TBPH -
When Is Theravance Biopharma’s Next Earnings Date?
The next quarterly earnings date for Theravance Biopharma is scheduled on May 8, 2024 -
When Is TBPH's next ex-dividend date?
Theravance Biopharma's next ex-dividend date is April 27, 2024 -
How To Buy Theravance Biopharma Stock?
You can buy Theravance Biopharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Theravance Biopharma Competitors
-
Who Are Theravance Biopharma's Competitors?
Below is a list of companies who compete with Theravance Biopharma or are related in some way:
Theravance Biopharma Dividend Yield
Data Unavailable
Theravance Biopharma Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 970.87% |
| Revenue: | 19.91% | -0.06% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 2 |
| Sell Recommendations: | 0 |
| Price Target: | 15.40 |
| Upside from Last Price: | 68.86% |